Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
Sponsor: Janssen Research & Development, LLC
Urothelial Cancer
United States, Argentina, Australia, Austria, Belgium +22 more
- A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung CancerActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Carcinoma, Non-Small-Cell Lung
United States, China, France, Germany, Italy +5 more
Sponsor: Janssen Research & Development, LLC
Hematological Malignancies
United States, Belgium, China, France, Germany +6 more
Sponsor: Bayer
Chronic Heart Failure
Japan
- A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland CarcinomaActive Not Recruiting
Sponsor: Janssen Pharmaceutical K.K.
Salivary Gland Neoplasms
Japan
Sponsor: Sanofi
Pruritus
United States, Argentina, Canada, China, France +8 more
- A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's DiseaseActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Crohn's Disease
United States, Australia, Austria, Belgium, Brazil +31 more
Sponsor: AbbVie
Atopic Dermatitis
United States, Canada, Colombia, Italy, Japan +4 more
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Psychosis Associated With Alzheimer's Disease
United States, Argentina, Belgium, Brazil, Bulgaria +26 more
Sponsor: Merck Sharp & Dohme LLC
Small Cell Lung Cancer
United States, Argentina, Australia, Chile, China +7 more
- A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque PsoriasisActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Plaque Psoriasis
United States, Argentina, Australia, Canada, China +11 more
- A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPCActive Not Recruiting
Sponsor: Aragon Pharmaceuticals, Inc.
Prostate Cancer
United States, Argentina, Australia, Brazil, Canada +17 more
Sponsor: Ultragenyx Pharmaceutical Inc
Glycogen Storage Disease Type Ia
United States, Brazil, Canada, Denmark, Germany +4 more
Sponsor: Aragon Pharmaceuticals, Inc.
Prostatic Neoplasms
United States, Argentina, Australia, Belgium, Brazil +11 more
Sponsor: Janssen Research & Development, LLC
Non-Muscle Invasive Bladder Neoplasms
United States, Argentina, Austria, Belgium, Brazil +15 more
- Psoriasis Longitudinal Assessment and RegistryActive Not Recruiting
Sponsor: Janssen Scientific Affairs, LLC
Psoriasis
United States, Argentina, Australia, Austria, Belgium +17 more
- A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's DiseaseRecruiting
Sponsor: Janssen Research & Development, LLC
Crohn's Disease
United States, Australia, Austria, Belgium, Brazil +12 more
Sponsor: Janssen Research & Development, LLC
Carcinoma, Non-Small-Cell Lung
United States, Australia, Belgium, Brazil, Canada +21 more
- Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell LymphomaActive Not Recruiting
Sponsor: Celgene
Large B-cell Lymphoma
United States, Argentina, Australia, Austria, Brazil +33 more
Sponsor: Asan Medical Center
Valve Replacement Surgery
Japan, South Korea
Sponsor: Takeda
Crohn's Disease
Japan
- A Study to Collect Data on the Use of Eylea in Babies Born Too Early Who Have a Condition of the Eye Where Blood Vessels Grow Abnormally in the Retina (Retinopathy of Prematurity)Active Not Recruiting
Sponsor: Bayer
Retinopathy of Prematurity · Newborns · Infants
Japan
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Nonsquamous Non-small-cell Lung
United States, Argentina, Australia, Austria, Brazil +15 more
- A Phase 2 Study of Sirolimus for Injection (Albumin-bound) in Patients With Progressive or Symptomatic Epithelioid HemangioendotheliomaNot Yet Recruiting
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Epithelioid Hemangioendothelioma
China
- Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung CancerActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Non-Small-Cell Lung Cancer
United States, Australia, Canada, China, France +5 more